Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Says Positive Topline Results From Completed Evidences-X Phase II(B) Clinical Trial Of Saroglitazar Mg

BRIEF-Zydus Lifesciences Says Positive Topline Results From Completed Evidences-X Phase II(B) Clinical Trial  Of Saroglitazar Mg 

- Zydus Lifesciences Ltd ZYDU.NS:

  • ZYDUS LIFESCIENCES - POSITIVE TOPLINE RESULTS FROM COMPLETED EVIDENCES-X PHASE II(B) CLINICAL TRIAL OF SAROGLITAZAR MG IN MASH

Source text: [ID:]

Further company coverage: ZYDU.NS


((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Zydus Lifesciences

See all news